focus -WSS

focus

author：explore 2025-09-27 12:48:47 - browse：125

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Timeline: Key moments in fight for gay rights

focus

WSS

The thinking behind the controversial eating disorder chatbot Tessa

Johnson & Johnson sues to stop Medicare negotiation

Millions may soon lose Medicaid when they don't have to

House passes resolution saying Israel isn't a 'racist or apartheid state'

A look at other Americans who have crossed into North Korea over the years

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

focus

focus

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What we know about the American soldier detained in North Korea

Medicare details structure of new drug price negotiation program

Robert Kennedy Jr.'s presidential campaign attracts GOP

Wildfire smoke exposes gaps in outdoor worker protections

15 die by electrocution after transformer explodes in northern India

The cancer drug shortage isn’t new — and neither are the solutions

Biden administration sends mixed signals on US soldier who crossed into North Korea

Tori Bowie and the unacceptable rates of Black maternal death

FDA approves first new drug developed for postpartum depression

knowledge

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Lack of darker skin in textbooks, journals harms patients of color

The thinking behind the controversial eating disorder chatbot Tessa

Patients, doctors are clashing about side effects of hormonal birth control

Biden administration plans revamp of organ transplant system

The thinking behind the controversial eating disorder chatbot Tessa

leisure time

knowledge

focus

knowledge